The top activity for fund was in 2011. The fund is constantly included in less than 2 investment rounds annually.
We can highlight the next thriving fund investment areas, such as Medical Device, Diabetes. Among the most popular portfolio startups of the fund, we may highlight Defymed.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are CeeD (Centre Europu00e9en d'u00e9tude du diabu00e8te), CTTM. In the next rounds fund is usually obtained by Emertec Gestion, CeeD (Centre Europu00e9en d'u00e9tude du diabu00e8te), Cap Innov'Est.
| Fund Name | Location |
| ACCIONA I'MNOVATION | Alcobendas, Madrid, Spain |
| Aka Capital | Bryanston, Gauteng, South Africa |
| Barton Capital | - |
| BayBG | Bayern, Germany, München |
| Beijing Runxin Touzi Guanli Zhongxin | Beijing, China, Fangshan |
| Case Western Reserve University | Cleveland, Ohio, United States |
| Cato BioVentures | Durham, North Carolina, United States |
| Dingshan Jiaxun | Beijing, Beijing, China |
| Eteron VC | Greater Poland Voivodeship, Poland, Poznań |
| Frost Venture Partners | California, San Juan Capistrano, United States |
| HPI Group | Salisbury, United Kingdom, Wiltshire |
| Madison Ventures Plus | Colorado, Greenwood Village, United States |
| National Federation of Agricultural Cooperative Associations | Chiyoda, Japan |
| Origin Capital | Dublin, Dublin, Ireland |
| Shenzhen Zhongrun Ruitai Investment Management | China, Guangdong, Shenzhen |
| The CapStreet Group | Houston, Texas, United States |
| The Walnut Group | Cincinnati, Ohio, United States |
| Tuatara Capital | New York, New York, United States |
| Twenty Seven Ventures | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Defymed | 04 Apr 2011 | Grand Est |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Defymed | 04 Apr 2011 | Grand Est |
